14th Dec 2006 07:01
Sinclair Pharma PLC14 December 2006 Sinclair Pharma plc signs deal with OMNI Preventative Care, a 3M ESPE Company, for sale of Aloclair(R) Spray in the US 14 December 2006, Godalming, UK: Sinclair Pharma plc ("Sinclair"), a specialtypharmaceutical company, announces that it has licensed the exclusive US rightsof its flagship mouth ulcer product, Aloclair(R) Spray, to OMNI Preventive Care,a 3M ESPE Company. Under the terms of the deal announced today, Sinclair will supply Aloclair Sprayto OMNI Preventive Care, which will be responsible for the marketing anddistribution of the product in the US market. Under the terms of the agreement,OMNI will have the exclusive rights to promote Aloclair Spray to dentalprofessionals and consumers. Sales are expected to commence within thisfinancial year Aloclair Spray has marketing clearance in the US and the EU, and Sinclair hasmarketing partners for the Aloclair range in 29 countries worldwide.Approximately 20% of the general population is affected by mouth ulcers, andthey are particularly common in children, women and the over 65s. Aloclair isalready penetrating this market with retail sales of more than £5m in the majorEU countries alone. Aloclair has a novel mode of action, forming a protective coating over the mouthulcer, providing fast and durable pain relief, without stinging on application.The spray presentation of Aloclair is a convenient pocket pack which can beapplied discreetly with a minimum of fuss. Dr Michael Flynn, CEO of Sinclair Pharma, said: "OMNI Preventive Care, a 3M ESPE Company is a substantial and respected company,with a strong track record in sales and marketing and excellent relationshipswith dental professionals. We are confident that OMNI will establish AloclairSpray as a successful new brand in the US. This deal consolidates our strongnetwork of marketing partners for our product portfolio, in the US and 60 othercountries around the world." Kevin Thomas, General Manager of OMNI Preventive Care, added: "We believe that with we are well placed to achieve strong sales of AloclairSpray in the US. Aloclair is a key addition to the range of dental products wecurrently market and we look forward to introducing our customers to thisimportant product." - ends - For further information please contact: Sinclair Pharma plc Dr Michael Flynn, CEO Tel: +44 (0) 1483 410 600Zoe McDougall, Communications Tel: +44 (0) 7973 792 520John Barrington-Carver, Communications Tel: +44 (0) 7831 655630Mike Killeen, US Tel: +1 972 478 4380 UKCapital MS&LMary Clark Tel +44 (0)20 7307 5340Halina Kukula GermanyMC ServicesRaimund Gabriel Tel +49 89 210 228 0Hilda Juhasz Notes to Editors: Sinclair Pharma plc Sinclair Pharma plc is an international specialty pharmaceutical company. Ithas a growing sales and marketing operation that is already present in France,Italy, UK, Spain and Portugal, and a complementary marketing partner networkthat spans 60 countries. Sinclair has proven expertise in acquiring or developing commercially attractiveand undervalued products, registering these products and bringing them to marketwithin a short time frame. The company focuses on niche therapeutic areas andits current portfolio includes products for dermatological conditions and oralhealth. The Sinclair Portfolio in the US Aloclair(R) Spray will add to the portfolio of Sinclair oral health productsthat are sold in the USA. Decapinol, for dental plaque and gingivitis, will bemarketed by OraPharma, a division of Johnson & Johnson. Rincinol and Canker-X(for mouth ulcers - sold as Aloclair(R) in non-US markets are currently marketedby Sunstar Butler in the US. Align Pharmaceuticals recently launched Numoisynlozenges and liquid (sold as SSTTM and SalinumTM in non-US markets) forxerostomia (dry mouth). XclairTM Sinclair's product for radiation dermatitis isalso licensed to Align Pharmaceuticals. Chester Valley Pharmaceuticals (CVP) islicensed to market Atopiclair(R) and SebclairTM (for atopic and seborrheicdermatitis respectively). Lastly GelclairTM (for oral mucositis) is licensed toHelsinn Healthcare. 3M Health Care 3M Health Care, one of 3M's six major business segments, provides world-classinnovative products and services to help health care professionals improve thepractice and delivery of patient care. 3M will continue to grow its vibrantHealth Care businesses globally serving multiple market segments. 3M ESPE, aleader in the dental industry, is a part of the 3M Health Care family. 3M ESPE 3M ESPE was founded in 2001 when 3M Dental Products Division and ESPE Dental AGcombined with the vision of becoming the leader in the global dental market byproviding the highest quality and innovation in products and services designedto help dental professionals help their patients. Led by Tom Engels, vicepresident and general manager, 3M ESPE is one of about 40 businesses that makeup 3M, a US publicly held, multinational organization with operations in morethan 60 countries. The two companies combine a rich history of business excellence and innovationsin dental materials and delivery systems. Through strong research anddevelopment programs, they have earned a reputation for quality and reliabilityin the product and services they offer the dental profession worldwide. Theresult of the combination is a company that is trusted and recognized worldwideas a source for more than 2,000 dental products and services designed to exceedcustomer expectations, and a continued adherence to the highest standard ofbusiness ethics. 3M ESPE manufactures and markets more than 2,000 products for use in the dentalindustry to improve the oral health of people around the world. Trusted brandsinclude 3MTM ESPETM FiltekTM Restorative Materials, 3MTM ESPETM ImpregumTMImpression Materials and 3MTM ESPETM PentamixTM 2 Electronic Mixing System, 3MTMESPETM RelyXTM brand of Cements, 3MTM ESPETM AdperTM PromptTM L-PopTM AdhesiveSystem and 3MTM ESPETM ImprintTM 3 VPS Impression Material. OMNI Preventive Care, a 3M ESPE Company OMNI Preventive Care helps dental professionals implement protocols that helpenhance the quality of care and productivity in the dental hygiene department.OMNI provides a broad range of oral preventive care products and services foruse in-office and at-home. OMNI is a wholly-owned subsidiary of 3M ESPE DentalProducts. For more information or to set up a staff meeting visit the OMNI website at www.omnipreventivecare.com or call OMNI at 800-445-3386. Other languages For versions of this press release in German, French, Spanish or Japanese pleasecontact [email protected] "Safe Harbor" Statement under the US Private Securities Litigation Reform Act of1995: Some or all of the statements in this document that relate to futureplans, expectations, events, performances and the like are forward-lookingstatements, as defined in the US Private Securities Litigation Reform Act of1995. Actual results of events could differ materially from those described inthe forward- looking statements due to a variety of factors. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma